Clinical trial
Chemotherapy in Treating Children With Neuroblastoma
NCT00002730 · New Approaches to Neuroblastoma Therapy Consortium, Other · Completed
Key facts
| NCT number | NCT00002730 |
|---|---|
| Title | Chemotherapy in Treating Children With Neuroblastoma |
| Official title | PILOT STUDY OF BUTHIONINE SULFOXIMINE (BSO) IN COMBINATION WITH MELPHALAN FOR HIGH RISK NEUROBLASTOMA PATIENTS |
| Lead sponsor | New Approaches to Neuroblastoma Therapy Consortium, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Neuroblastoma |
| Intervention type | Drug |
| Interventions | buthionine sulfoximine, melphalan |
| Start date | Jun 1, 1996 |
| First posted | Sep 1, 2004 |
| Last update posted | Nov 20, 2024 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: